Comments

Insmed Stock Price, Quotes and Forecasts

Q: What sector and industry does Insmed (INSM) operate in?

Insmed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

INSMNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Insmed (INSM) Forecast

News Earnings Insmed (INSM) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Insmed Stock Price, Quotes and Forecasts | NASDAQ:INSM | Benzinga

Explore Insmed stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for INSM.

Open	$79.94
Close	-
Volume / Avg.	81.77K / 1.79M
Day Range	$78.76 - $80.00
52 Wk Range	21.92 - 84.91
Market Cap	$14.29B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	8.18%
Days to Cover	6.85

Recent News

Are Small-Cap Stocks A Buy After Russell 2000 Correction?

Investors are questioning the value of small-cap stocks, as reflected by Russell 2000's 15% drop. Some top stocks saw even bigger declines.

Hayden Buckfire

First Trust's New Small-Cap ETF Aims To Combine Growth With Income

First Trust launches actively managed FTKI ETF, using buy-write strategy for steady income and small-cap exposure. Expense ratio is 0.85%.

Chandrima Sanyal

Lung Disease-Focused Insmed 'Is An Attractive Midcap Biotech,' Analyst Says

RBC Capital initiates Insmed with an Outperform rating, citing brensocatib's launch potential and Arikayce's growth. FDA decision on brensocatib due August 2025.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$79.94
Close	-
Volume / Avg.	81.77K / 1.79M
Day Range	$78.76 - $80.00
52 Wk Range	21.92 - 84.91
Market Cap	$14.29B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	8.18%
Days to Cover	6.85

About Insmed Inc

Sector

Health Care

Industry

Biotechnology

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare d...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Insmed (INSM) stock?

You can purchase shares of Insmed (NASDAQ:INSM) through any online brokerage.

View our list of the best stock brokerages

Who are Insmed (INSM) competitors?

Other companies in Insmed’s space includes: BeiGene (NASDAQ:ONC), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for Insmed (INSM) stock?

Insmed has a consensus price target of $84.26.

What is the current price for Insmed (INSM)?

The stock price for Insmed (NASDAQ: INSM) is $78.975 last updated March 25, 2025 at 10:16 AM EDT.

Does Insmed (INSM) pay a dividend?

There are no upcoming dividends for Insmed.

When is Insmed (NASDAQ:INSM) reporting earnings?

Insmed’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is Insmed (INSM) going to split?

There is no upcoming split for Insmed.

What sector and industry does Insmed (INSM) operate in?

Insmed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.